logo
  

Primerica Promotes Glenn Williams To CEO

Primerica Inc. (PRI), a distributor of financial products, said that its board has promoted Glenn Williams, currently the company's President, to Chief Executive Officer and also elected him to the Board, effective April 1, 2015.

The current Co-Chief Executive Officers, Richard (Rick) Williams and John Addison Jr., will remain members of the Primerica Board.

In their new roles, Rick Williams, who has been with Primerica since 1989, will be non-executive Chairman of the Board and John Addison, who has been with the company since 1982, will be non-executive Chairman of Primerica Distribution.

The company also announced that it has promoted Peter Schneider to the position of President, also effective April 1, 2015.

Rounding out Primerica's executive group are Alison Rand, who has served as the Company's Chief Financial Officer since 2000, and Gregory Pitts, a 30-year Primerica veteran who will continue as the company's Chief Operating Officer, the company said.

Glenn Williams, age 55, began his career with Primerica in 1981 as a member of the company's sales force. He joined the Home Office team in 1983. In 1985, Williams moved to Canada as part of Primerica's international expansion team, where he spent 15 years in roles of increasing responsibility. He led Primerica Canada as President and Chief Executive Officer from 1996 to 2000. In 2000, he returned to Primerica's Duluth, Georgia-based headquarters as Executive Vice President of Field and Product Marketing for international operations. In 2005, Primerica elevated Williams to President of the Company.

Schneider has served as the Company's Executive Vice President and General Counsel since June 2000 and as Chief Administrative Officer since 2010, and he will retain his General Counsel duties for the foreseeable future.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT